Correction : Cepharanthine hydrochloride reverses the mdr1 (P-glycoprotein)-mediated esophageal squamous cell carcinoma cell cisplatin resistance through JNK and p53 signals
Copyright: © 2021 Zhou et al..
[This corrects the article DOI: 10.18632/oncotarget.22676.].
| Errataetall: |
ErratumFor: Oncotarget. 2017 Nov 27;8(67):111144-111160. - PMID 29340044 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:12 |
|---|---|
| Enthalten in: |
Oncotarget - 12(2021), 1 vom: 05. Jan., Seite 61-62 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Zhou, Pengjun [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Revised 18.01.2021 published: Electronic-eCollection ErratumFor: Oncotarget. 2017 Nov 27;8(67):111144-111160. - PMID 29340044 Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.18632/oncotarget.27638 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM320193365 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM320193365 | ||
| 003 | DE-627 | ||
| 005 | 20231225173046.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.18632/oncotarget.27638 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1067.xml |
| 035 | |a (DE-627)NLM320193365 | ||
| 035 | |a (NLM)33456714 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Zhou, Pengjun |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Correction |b Cepharanthine hydrochloride reverses the mdr1 (P-glycoprotein)-mediated esophageal squamous cell carcinoma cell cisplatin resistance through JNK and p53 signals |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 18.01.2021 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a ErratumFor: Oncotarget. 2017 Nov 27;8(67):111144-111160. - PMID 29340044 | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a Copyright: © 2021 Zhou et al. | ||
| 520 | |a [This corrects the article DOI: 10.18632/oncotarget.22676.] | ||
| 650 | 4 | |a Published Erratum | |
| 700 | 1 | |a Zhang, Rong |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Ying |e verfasserin |4 aut | |
| 700 | 1 | |a Xu, Dandan |e verfasserin |4 aut | |
| 700 | 1 | |a Zhang, Li |e verfasserin |4 aut | |
| 700 | 1 | |a Qin, Jinhong |e verfasserin |4 aut | |
| 700 | 1 | |a Su, Guifeng |e verfasserin |4 aut | |
| 700 | 1 | |a Feng, Yue |e verfasserin |4 aut | |
| 700 | 1 | |a Chen, Hongce |e verfasserin |4 aut | |
| 700 | 1 | |a You, Siyuan |e verfasserin |4 aut | |
| 700 | 1 | |a Rui, Wen |e verfasserin |4 aut | |
| 700 | 1 | |a Liu, Huizhong |e verfasserin |4 aut | |
| 700 | 1 | |a Chen, Suhong |e verfasserin |4 aut | |
| 700 | 1 | |a Chen, Hongyuan |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Yifei |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Oncotarget |d 2010 |g 12(2021), 1 vom: 05. Jan., Seite 61-62 |w (DE-627)NLM199620113 |x 1949-2553 |7 nnns |
| 773 | 1 | 8 | |g volume:12 |g year:2021 |g number:1 |g day:05 |g month:01 |g pages:61-62 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.18632/oncotarget.27638 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 12 |j 2021 |e 1 |b 05 |c 01 |h 61-62 | ||